Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Reesink

Showing results (21-30 of 250) with videos related to

Pageof 25
Sort By:
Vox Sanguinis|January 1, 1989
A new cellulose acetate filter to remove leukocytes from buffy-coat-poor red cell concentratesR N Pietersz, W J Dekker, H W Reesink
Vox Sanguinis|January 1, 1973
Standardization and modification of the haemagglutination (inhibition) techniques for the determination of HBAg and anti-HBAg antibodiesH W Reesink, W J Duimel, H G Brummelhuis
Vox Sanguinis|January 1, 1990
Comparison of a conventional quadruple-bag system with a 'top-and-bottom' system for blood processingR N Pietersz, W J Dekker, H W Reesink
Vox Sanguinis|January 1, 1985
Platelet concentrates stored in plasma for 72 hours at 22 degrees C prepared from buffycoats of citrate-phosphate-dextrose blood collected in a quadruple-bag saline-adenine-glucose-mannitol systemR N Pietersz, J A Loos, H W Reesink
Annals of Internal Medicine|January 15, 1995
Transmission of hepatitis C virus to spousesE P Mauser-Bunschoten, D Bresters, H W Reesink
Lancet (London, England)|August 8, 1987
Earlier detection of HIV and second-generation antibody assaysP N Lelie, H W Reesink, J G Huisman
Journal of Medical Virology|November 1, 1987
Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccineP N Lelie, H W Reesink, C J Lucas
Blut|April 1, 1987
Survival in vivo of platelets stored for 48 hours in the buffycoat at 4 degrees C compared to platelet rich plasma stored at 22 degrees CR N Pietersz, J A Loos, H W Reesink
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Coinfection with hepatitis C virus and HIV]Th A Ruys, H W Reesink, J M Lange
Vox Sanguinis|January 1, 1995
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodiesH Vrielink, C L van der Poel, H W Reesink
Pageof 25

Showing results (21-30 of 250) with videos related to

Sort By:
Pageof 25
Vox Sanguinis|January 1, 1989
A new cellulose acetate filter to remove leukocytes from buffy-coat-poor red cell concentratesR N Pietersz, W J Dekker, H W Reesink
Vox Sanguinis|January 1, 1973
Standardization and modification of the haemagglutination (inhibition) techniques for the determination of HBAg and anti-HBAg antibodiesH W Reesink, W J Duimel, H G Brummelhuis
Vox Sanguinis|January 1, 1990
Comparison of a conventional quadruple-bag system with a 'top-and-bottom' system for blood processingR N Pietersz, W J Dekker, H W Reesink
Vox Sanguinis|January 1, 1985
Platelet concentrates stored in plasma for 72 hours at 22 degrees C prepared from buffycoats of citrate-phosphate-dextrose blood collected in a quadruple-bag saline-adenine-glucose-mannitol systemR N Pietersz, J A Loos, H W Reesink
Annals of Internal Medicine|January 15, 1995
Transmission of hepatitis C virus to spousesE P Mauser-Bunschoten, D Bresters, H W Reesink
Lancet (London, England)|August 8, 1987
Earlier detection of HIV and second-generation antibody assaysP N Lelie, H W Reesink, J G Huisman
Journal of Medical Virology|November 1, 1987
Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccineP N Lelie, H W Reesink, C J Lucas
Blut|April 1, 1987
Survival in vivo of platelets stored for 48 hours in the buffycoat at 4 degrees C compared to platelet rich plasma stored at 22 degrees CR N Pietersz, J A Loos, H W Reesink
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Coinfection with hepatitis C virus and HIV]Th A Ruys, H W Reesink, J M Lange
Vox Sanguinis|January 1, 1995
Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodiesH Vrielink, C L van der Poel, H W Reesink
Pageof 25